Insmed, Inc. (INSM) Social Stream
INSMED INC (INSM) Price Targets From Analysts
Use the tables below to see what analysts covering INSMED INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-10-29 | 8 | $60 | $43 | $52.5 | $29.11 | 80.35% |
2021-12-06 | 9 | $60 | $43 | $52.444 | $29.11 | 80.16% |
2021-12-21 | 8 | $60 | $43 | $52.444 | $29.11 | 80.16% |
2022-01-31 | 8 | $60 | $42 | $51.333 | $29.11 | 76.34% |
2022-02-18 | 8 | $60 | $43 | $51.666 | $29.11 | 77.49% |
2022-02-22 | 8 | $57 | $40 | $50.555 | $29.11 | 73.67% |
2022-05-06 | 8 | $56 | $40 | $50 | $29.11 | 71.76% |
2022-05-09 | 8 | $56 | $41 | $49.888 | $29.11 | 71.38% |
2022-05-24 | 9 | $56 | $41 | $49.7 | $29.11 | 70.73% |
2022-08-05 | 9 | $56 | $41 | $49.2 | $29.11 | 69.01% |
2022-10-12 | 9 | $56 | $41 | $49 | $29.11 | 68.33% |
2022-10-21 | 8 | $55 | $41 | $48.666 | $29.11 | 67.18% |
2022-10-28 | 8 | $55 | $41 | $48.222 | $29.11 | 65.65% |
2022-11-07 | 8 | $55 | $37 | $47.111 | $29.11 | 61.84% |
2022-11-22 | 9 | $55 | $37 | $46.3 | $29.11 | 59.05% |
2022-11-28 | 9 | $55 | $37 | $46.2 | $29.11 | 58.71% |
2022-12-09 | 11 | $55 | $28 | $43.916 | $29.11 | 50.86% |
2023-01-06 | 11 | $55 | $28 | $43.916 | $29.11 | 50.86% |
2023-01-09 | 11 | $55 | $28 | $42.916 | $29.11 | 47.43% |
2023-02-14 | 11 | $55 | $28 | $42.25 | $29.11 | 45.14% |
2023-02-19 | 11 | $52 | $28 | $40.818 | $29.11 | 40.22% |
2023-04-19 | 11 | $52 | $28 | $40 | $29.11 | 37.41% |
2023-04-24 | 11 | $52 | $28 | $40.181 | $29.11 | 38.03% |
2023-05-09 | 11 | $52 | $28 | $39.909 | $29.11 | 37.1% |
2023-06-06 | 10 | $52 | $28 | $39.909 | $29.11 | 37.1% |
2023-07-11 | 9 | $52 | $28 | $40.3 | $29.11 | 38.44% |
2023-07-26 | 10 | $52 | $28 | $41.181 | $29.11 | 41.47% |
2023-08-04 | 10 | $52 | $30 | $41.636 | $29.11 | 43.03% |
2023-08-07 | 10 | $52 | $30 | $41.818 | $29.11 | 43.66% |
2023-09-05 | 10 | $52 | $30 | $42 | $29.11 | 44.28% |
2023-09-06 | 11 | $52 | $33 | $42.454 | $29.11 | 45.84% |
2023-09-07 | 11 | $52 | $33 | $42.416 | $29.11 | 45.71% |
2023-10-26 | 11 | $54 | $33 | $43.083 | $29.11 | 48% |
2023-10-30 | 12 | $52 | $35 | $42.272 | $29.11 | 45.21% |
2023-12-08 | 14 | $55 | $35 | $43.545 | $29.11 | 49.59% |
2023-12-19 | 14 | $55 | $35 | $42.833 | $29.11 | 47.14% |
The Trend in the Analyst Price Target
Over the past 43 months, INSM's average price target has gone down $1.28.
Over the past 49 weeks, INSM's average upside potential has been 89.84%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-01-13 | 11 | 55 | 28 | 42.250 | 19.45 | 117.22% |
2023-05-09 | 10 | 52 | 28 | 39.909 | 18.93 | 110.82% |
2023-09-07 | 11 | 52 | 33 | 42.416 | 26.59 | 59.52% |
2023-10-30 | 13 | 52 | 35 | 42.272 | 23.80 | 77.61% |
2023-12-08 | 14 | 55 | 35 | 43.545 | 27.96 | 55.74% |
INSM Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 14 | 0 | 0 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
INSM's average broker recommendation rating improved by 0 over the prior 41 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- INSMED INC's upside potential (average analyst target price relative to current price) is greater than 3276.6% of all US stocks.
- INSMED INC's variance in analysts' estimates is lower than -1178.59% of Pharmaceutical Products stocks.
- INSM has a greater number of analysts covering the stock than 3256.53% of stocks in the mid market cap category.
- INSM has a greater average analyst price target than 3089.12% of Pharmaceutical Products stocks.
Stocks similar to INSMED INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SAVA, CYTK, and TGTX.
View All Top Stocks by Price Target
Is INSM a Buy, Hold or Sell? See the POWR Ratings now!